Abstract:Many Chinese herbs are well known for their neuroprotective and anti-oxidant properties. Extracts of Salvia miltiorrhiza and Anemarrhenae asphodeloides, tanshinone IIA (tanIIA), salvianolic acid B (Sal B) and sarsasapogenin (ML-1), were selected to study their dissociation potential towards Aβ42 peptide fibrils and neuroprotective effect on cells. Moreover, derivatives of sarsasapogenin (ML-2, ML-3 and ML-4) have been prepared by the addition of modified carbamate moiety. TanIIA and Sal B have shown to possess a strong ability to dissociate Aβ42 fibrils. The dissociation potential of ML-1 increased upon the introduction of carbamate moiety with N-heterocycles. In silico data revealed that derivatives ML-4 and Sal B interact with Aβ42 regions responsible for fibril stabilization through hydrogen bonds. Contrary, tanIIA binds close to a central hydrophobic region, which may lead to destabilization of fibrils. Sarsasapogenin derivative ML-2 decreased nitride oxide production, and derivative ML-4 enhanced the growth of neurites. The reported data highlight the possibility of using active compounds to design novel treatment agents for Alzheimer's disease.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the effects of compounds extracted from traditional Chinese medicine on the pathophysiological mechanisms related to Alzheimer's disease (AD), especially the depolymerization potential of these compounds on Aβ42 peptide fibrils and their neuroprotective effects. Specifically, tanshinone IIA (TanIIA) and salvianolic acid B (Sal B) in the extract of Salvia miltiorrhiza, as well as sarsasapogenin (Sarsasapogenin, ML - 1) and its derivatives (ML - 2, ML - 3, ML - 4) in the extract of Anemarrhenae asphodeloides were studied for their depolymerization ability on Aβ42 fibrils, and the antioxidant, anti - inflammatory and neurite - promoting abilities of these compounds at the cellular level were evaluated. ### Main research contents: 1. **Depolymerization activity**: The depolymerization effects of the compounds on Aβ42 fibrils were evaluated by methods such as thioflavin T fluorescence assay, atomic force microscopy (AFM) and circular dichroism (CD). 2. **Neuroprotective effects**: The neuroprotective effects of the compounds were evaluated by cytotoxicity test (WST - 1 assay), cell cycle analysis, H₂O₂ - induced cytotoxicity protection experiment and lipopolysaccharide (LPS) - induced nitric oxide (NO) production experiment. 3. **Promotion of neurite growth**: The promoting effects of the compounds on the growth of nerve cells were observed by neurite outgrowth assay. ### Research background: - **Alzheimer's disease (AD)**: AD is a neurodegenerative disease related to the fibrillation of amyloid - β (Aβ) peptide. The main pathological features include the formation of Aβ42 fibrils and the gradual loss of nerve cells. - **Application of traditional Chinese medicine**: Many traditional Chinese medicines have antioxidant and neuroprotective effects and may become new sources of drugs for the treatment of AD. ### Research purposes: - **Evaluation of depolymerization activity**: To determine whether these compounds can effectively depolymerize Aβ42 fibrils, thereby reducing the formation of amyloid plaques. - **Evaluation of neuroprotective effects**: To explore whether these compounds have antioxidant, anti - inflammatory and nerve cell growth - promoting effects at the cellular level, so as to evaluate their feasibility as potential drugs for the treatment of AD. ### Research methods: - **In vitro experiments**: The depolymerization activity and neuroprotective effects of the compounds were systematically evaluated by a variety of biophysical and cell biological techniques. - **Computational simulation**: Computational methods such as molecular docking and binding energy calculation were used to explore the binding mechanisms between the compounds and Aβ42 fibrils. ### Conclusions: - **Depolymerization activity**: Salvianolic acid B (Sal B) showed the strongest depolymerization activity, followed by tanshinone IIA (TanIIA) and sarsasapogenin derivative ML - 4. - **Neuroprotective effects**: Some compounds such as ML - 2 reduced the production of nitro - oxides, and ML - 4 promoted the growth of neurites. - **Binding mechanism**: The results of computational simulation showed that Sal B and ML - 4 mainly bind to the hydrophilic regions of Aβ42 fibrils, while TanIIA tends to bind to the hydrophilic core regions. These binding modes help to explain their different depolymerization activities. This study provides important scientific basis for the development of new drugs for the treatment of AD.

Extracts from Chinese herbs with anti-amyloid and neuroprotective activities

Salvianic Borneol Ester Reduces Β-Amyloid Oligomers and Prevents Cytotoxicity.

In-vitro Neuro-2a cytotoxicity analysis and molecular docking investigation on potential anti-amyloid agents from Adiantum lunulatum

A Novel Based-Network Strategy to Identify Phytochemicals from Radix Salviae Miltiorrhizae (Danshen) for Treating Alzheimer's Disease

Cryptotanshinione Inhibits Β-Amyloid Aggregation and Protects Damage from Β-Amyloid in SH-SY5Y Cells

Molecular docking and molecular dynamics simulation revealed potential compounds in Salvia miltiorrhiza for inhibiting enzymes and receptors in Alzheimer’s disease

Salvianolic Acid A, a Polyphenolic Derivative from Salvia Miltiorrhiza Bunge, As a Multifunctional Agent for the Treatment of Alzheimer's Disease.

Salvianolic acid B inhibits Abeta fibril formation and disaggregates preformed fibrils and protects against Abeta-induced cytotoxicty

Sinomenine inhibits microglial activation by Aβ and confers neuroprotection

An in Vitro Study on Probable Inhibition of Cerebrovascular Disease by Salidroside As a Potent Small Molecule Against Induction of Protein Amyloid Fibrils and Cytotoxicity

Unraveling potential neuroprotective mechanisms of herbal medicine for Alzheimer's diseases through comprehensive molecular docking analyses

Design and Synthesis of New Benzo[d]oxazole-Based Derivatives and Their Neuroprotective Effects on β-Amyloid-Induced PC12 Cells

Anti-Alzheimer's disease activity of secondary metabolites from Xanthoceras sorbifolia Bunge.

Novel Cinnamamide-Dibenzylamine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties As Innovative Drugs for Alzheimer's Disease

Polyoxygenated sesquiterpenoids from Salvia castanea and their potential anti-Alzheime's disease bioactivities

Design, synthesis and evaluation of multifunctional salphen derivatives for the treatment of Alzheimer's disease

N-salicyloyl tryptamine derivatives as potential therapeutic agents for Alzheimer's disease with neuroprotective effects

A Systematic Screening of Traditional Chinese Medicine Identifies Two Novel Inhibitors Against the Cytotoxic Aggregation of Amyloid Beta

Design, Synthesis and Biological Evaluation of 3-Piperazinecarboxylate Sarsasapogenin Derivatives As Potential Multifunctional Anti-Alzheimer Agents.

Protective Effects of Bajijiasu in a Rat Model of Aβ₂₅₋₃₅-induced Neurotoxicity.

Akebia Saponin D, a Saponin Component from Dipsacus Asper Wall, Protects PC 12 Cells Against Amyloid‐β Induced Cytotoxicity